Skip to main content
. 2021 Jan 9;22(2):612. doi: 10.3390/ijms22020612

Figure 1.

Figure 1

The figure depicts the main druggable genetic targets and their involvement in the main signaling pathways in non-small cell lung cancer. EGFR: epidermal growth factor receptor; HER2: human epidermal growth factor receptor 2; ERK: extracellular signal-related kinase.